DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Japan
  • /
  • Healthcare
Author Program NEWCreate Narrative
3649 logo

FINDEX Inc. Stock Price

TSE:3649 Community·JP¥20.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

3649 Share Price Performance

JP¥853.00
38.00 (4.66%)
​
JP¥853.00
38.00 (4.66%)
​
Price JP¥853.00
Sun, 13 Sep 26
Share Pricen/a

3649 Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

0 Risks
1 Reward
View Full Analysis

FINDEX Inc. Key Details

JP¥6.1b

Revenue

JP¥2.1b

Cost of Revenue

JP¥4.0b

Gross Profit

JP¥2.9b

Other Expenses

JP¥1.1b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Nov 12, 2026
46.31
65.54%
18.45%
0%
View Full Analysis

About 3649

Founded
1985
Employees
325
CEO
Teruo Aibara
WebsiteView website
findex.co.jp

FINDEX Inc. offers medical devices in Japan. It operates through Medical Business, Public Business, and Healthtech Business segments. The company provides Claio image filing system, C-Scan paper and digital document management system, DocuMaker document creation system, PDI+MoveBy referral information management system, C-Note medical record writing system, MapleNote perinatal system, REMORA electronic medical record, ID-Cam/Claio-Cam digital camera solution, UniversalSearcher medical big data search system, FAXde regional collaboration FAX referral management system, LIS endoscope system endoscopy department system, LIS ultrasound system ultrasound department system, ProRad RS radiology reporting system, gateway system, RemoTalkCloud, remote sharing app for medical information, C-Nys / C-Nys ME Nystagmus analysis support system, Cloud backup service security service, PiCls Medical Avenue for patient information app, PiCls On-examination online medical support system, PiCls AAdE-report electronic tracing report service, PiCls booking assistant first appointment online reservation service, PiCls connect medical institution collaboration service, WebeLi, and CocktailAI ,a generative AI for medical text generation; and DigiWorker, an RPA tool for healthcare. It also offers REMORA+Claio, an ophthalmology solution; G-QuICC DB Program, a glaucoma protocol; ENT package; DocuMaker Cloud, a medical certificate and other document creation service; REMORA Cloud, a cloud-based electronic medical record; C-Note + Claio, an ophthalmology solution; ClaioDashboard integrated viewing system; DocuMaker office, a document management system for administrative department; DocuMakerShelf, an electronic bookkeeping solution; and GAP-screener, line-of-sight analysis type perimeter for medical examination facilities. The company was formerly known as PSC Inc. and changed its name to FINDEX Inc. in November 2014. FINDEX Inc. was incorporated in 1985 and is headquartered in Chiyoda, Japan.

Recent 3649 News & Updates

Recent updates

No updates

FINDEX Inc. Competitors

7741 logo

HOYA

Symbol: TSE:7741
Market cap: JP¥7.6t
4543 logo

Terumo

Symbol: TSE:4543
Market cap: JP¥3.3t
7733 logo

Olympus

Symbol: TSE:7733
Market cap: JP¥2.1t
2413 logo

M3

Symbol: TSE:2413
Market cap: JP¥1.1t
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide